Somatic structural variation and cancer

Briefings in Functional Genomics

Volumn 14, Issue 5, 2015, Pages 339-351

  Tubio, Jose M C ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Cancer genome; Driver mutation; Mutational process; somatic structural variation

Indexed keywords

DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME STRUCTURE; DICENTRIC CHROMOSOME; DNA SEQUENCE; DOUBLE MINUTE CHROMOSOME; GENETIC VARIABILITY; HUMAN; MEDULLOBLASTOMA; MICRONUCLEUS; NEXT GENERATION SEQUENCING; NONHUMAN; ONCOGENE; PROSTATE CANCER; PROTO ONCOGENE; PSEUDOGENE; TUMOR SUPPRESSOR GENE; WART VIRUS; GENETIC VARIATION; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; MUTATION; NEOPLASM; PROCEDURES;

GENOME, HUMAN; GENOMIC STRUCTURAL VARIATION; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; NEOPLASMS;

EID: 84942308016     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/elv016     Document Type: Article

References (70)

1. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009;458:719-24.
2. Korbel JO, Urban AE, Affourtit JP, et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007;318:420-6.
3. Campbell PJ, Stephens PJ, Pleasance ED, et al. Identification of somatically acquired rearrangements in cancer using genome- wide massively parallel paired-end sequencing. Nat Genet 2008;40:722-9.
4. Yang L, Luquette LJ, Gehlenborg N, et al. Diverse mechanisms of somatic structural variations in human cancer genomes. Cell 2013;153:919-29.
5. Stephens PJ, Greenman CD, Fu B, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011;144:27-40.
6. Garsed DW, Marshall OJ, Corbin VD, et al. The architecture and evolution of cancer neochromosomes. Cancer Cell 2014;26:653-67.
7. Li Y, Schwab C, Ryan SL, et al. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature 2014;508:98-102.
8. Rausch T, Jones DT, Zapatka M, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangementswith TP53mutations. Cell 2012;148:59-71.
9. Crasta K, Ganem NJ, Dagher R, et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 2012;482:53-8.
10. Korbel JO, Campbell PJ. Criteria for inference of chromothripsis in cancer genomes. Cell 2013;152:1226-36.
11. Zhang CZ, Leibowitz ML, Pellman D. Chromothripsis and beyond:rapid genome evolution from complex chromosomal rearrangements. Genes Dev 2013;27:2513-30.
12. Tubio JM, Estivill X. Cancer: when catastrophe strikes a cell. Nature 2011;470:476-7.
13. Jones MJ, Jallepalli PV, Chromothripsis. Chromosomes in crisis. Dev Cell 2012;23:908-17.
14. McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941;26:234-82.
15. Bunting SF, Nussenzweig A. End-joining, translocations and cancer. Nat Rev Cancer 2013;13:443-54.
16. Artandi SE, Chang S, Lee SL, Alson S, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000;406:641-5.
17. Difilippantonio MJ, Petersen S, Chen HT, et al. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med 2002;196:469-80.
18. Zhu C, Mills KD, Ferguson DO, et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002;109:811-21.
19. Hoffelder DR, Luo L, Burke NA, et al. Resolution of anaphase bridges in cancer cells. Chromosoma 2004;112:389-97.
20. Robinson HM, Harrison CJ, Moorman AV, et al. Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle. Genes Chromosomes Cancer 2007;46:318-26.
21. Strefford JC, van Delft FW, Robinson HM, et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Proc Natl Acad Sci USA 2006;103:8167-72.
22. Campbell PJ, Yachida S, Mudie LJ, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010;467:1109-13.
23. Thomas L, Stamberg J, Gojo I, et al. Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature. Am J Hematol 2004;77:55-61.
24. Bigner SH, Mark J, Bigner DD. Cytogenetics of human brain tumors. Cancer Genet Cytogenet 1990;47:141-54.
25. Nielsen JL, Walsh JT, Degen DR, et al. Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer. Cancer Genet Cytogenet 1993;65:120-4.
26. Collins VP. Gene amplification in human gliomas. Glia 1995;15:289-96.
27. Storlazzi CT, Fioretos T, Surace C, et al. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet 2006;15:933-42.
28. Morel F, Bris MJ, Herry A, et al. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib. Eur J Haematol 2003;70:235-9.
29. Carroll SM, DeRose ML, Gaudray P, et al. Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol Cell Biol 1988;8:1525-33.
30. Tomlins SA, Laxman B, Dhanasekaran SM, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007;448:595-9.
31. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-8.
32. Berger MF, Lawrence MS, Demichelis F, et al. The genomic complexity of primary human prostate cancer. Nature 2011;470:214-20.
33. Baca SC, Prandi D, Lawrence MS, et al. Punctuated evolution of prostate cancer genomes. Cell 2013;153:666-77.
34. Harrison CJ, Moorman AV, Barber KE, et al. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol 2005;129:520-30.
35. Bateman CM, Colman SM, Chaplin T, et al. Acquisition of genome- wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia. Blood 2010;115:3553-8.
36. Papaemmanuil E, Rapado I, Li Y, et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet 2014;46:116-25.
37. Holmfeldt L, Wei L, Diaz-Flores E, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 45:242-52.
38. Fugmann SD, Lee AI, Shockett PE, et al. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol 2000;18:495-527.
39. Kidwell MG, Lisch DR. Perspective: transposable elements, parasitic DNA, and genome evolution. Evolution 2001;55:1-24.
40. Northcott PA, Lee C, Zichner T, et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 2014;511:428-34.
41. Küppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001;20:5580-94.
42. Kinoshita K, Honjo T. Linking class-switch recombination with somatic hypermutation. Nat Rev Mol Cell Biol 2001;2:493-503.
43. Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol 2000;18:3707-21.
44. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994;372:143-9.
45. Henderson A, Calame K. Transcriptional regulation during B cell development. Annu Rev Immunol 1998;16:163-200.
46. Truffinet V, Pinaud E, Cogné N, et al. The 30 IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype. J Immunol 2007;179:6033-42.
47. Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985;318:533-8.
48. Gostissa M, Yan CT, Bianco JM, et al. Long-range oncogenic activation of Igh-c-myc translocations by the Igh 30 regulatory region. Nature 2009;462:803-7.
49. Kazazian HH, Jr. Mobile elements: drivers of genome evolution. Science 2004;303:1626-32.
50. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
51. Tubio JM, Li Y, Ju YS, et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 2014;345:1251343.
52. Lee E, Iskow R, Yang L, et al. Landscape of somatic retrotransposition in human cancers. Science 2012;337:967-71.
53. Helman E, Lawrence MS, Stewart C, et al. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res 2014;24:1053-63.
54. Shukla R, Upton KR, Muñoz-Lopez M, et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 2013;153:101-11.
55. Kazazian HH, Jr. Processed pseudogene insertions in somatic cells. Mob DNA 2014;5:20.
56. Moran JV, DeBerardinis RJ, Kazazian HH, Jr. Exon shuffling by L1 retrotransposition. Science 1999;283:1530-4.
57. Pitkänen E, Cajuso T, Katainen R, et al. Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer. Oncotarget 2014;5:853-9.
58. Cooke SL, Shlien A, Marshall J, et al. Processed pseudogenes acquired somatically during cancer development. Nat Commun 2014;5:3644.
59. Ewing AD, Ballinger TJ, Earl D, et al. Retrotransposition of gene transcripts leads to structural variation in mammalian genomes. Genome Biol 2013;14:R22.
60. Zur Hausen H. The search for infectious causes of human cancers: where and why (Nobel lecture). Angew Chem Int Ed [Engl] 2009;48:5798-808.
61. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010;10:878-89.
62. Tang KW, Alaei-Mahabadi B, Samuelsson T, et al. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun 2013;4:2513.
63. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006;110:525-41.
64. Akagi K, Li J, Broutian TR, et al. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res 2014;24:185-99.
65. Peter M, Stransky N, Couturier J, et al. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J Pathol 2010;221:320-30.
66. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007;7:11-22.
67. Lace MJ, Anson JR, Klussmann JP, et al. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. J Virol 2011;85:1645-54.
68. Khoury JD, Tannir NM, Williams MD, et al. Landscape of DNA virus associations across human malignant cancers:analysis of 3,775 cases using RNA-Seq. J Virol 2013;87:8916-26.
69. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014;507:315-22.
70. Jiang Z, Jhunjhunwala S, Liu J, et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res 2012;22:593-601.